Evidence map›Paper›PMID 38259090›Full record

ArticleAntimicrobial agents and chemotherapy2024

AgrA directly binds to the promoter of

Xueer Liu, Yangyan Wang, Wenjiao Chang, Yuanyuan Dai, Xiaoling Ma

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Loratadine decreases virulence of methicillin-resistantbioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Repurposing Diflunisal as an Antivirulence Agent AgainstInfectious microbes & diseases · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xueer LiuDepartment of Clinical Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yangyan WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.
Wenjiao ChangDepartment of Clinical Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yuanyuan DaiDepartment of Clinical Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Xiaoling MaDepartment of Clinical Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.ORCID 0000-0002-2732-8669
University of Science and Technology of China · CNFirst Affiliated Hospital of Wannan Medical College · CN

Funding

MOST | National Natural Science Foundation of China (NSFC) 81772248MOST | National Natural Science Foundation of China (NSFC) 81802066MOST | National Natural Science Foundation of China (NSFC) 82272393
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Staphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsHumansPromoter Regions, GeneticVancomycinAnti-Bacterial AgentsBacterial ProteinsVancomycinAgrStaphylococcus aureusvancomycinvraSR

Identifiers

PMID38259090
PMCPMC10916378
OpenAlexW4391135842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.